Total | Diabetes | No diabetes | P-value | |
---|---|---|---|---|
Age, years (SD) | 62 (19) | 68 (14) | 60 (20) | < 0.0001 |
Female, n (%) | 899 (50) | 264 (44) | 635 (53) | 0.0004 |
BMI, kg/m2 (SD) | 29 (13) | 31 (14) | 28 (12) | < 0.0001 |
Race | ||||
White, n (%) | 1181 (65) | 377 (63) | 804 (67) | 0.0884 |
Black, n (%) | 251 (14) | 82 (14) | 169 (14) | |
Asian, n (%) | 133 (7) | 56 (9) | 77 (6) | |
Other, n (%) | 244 (13) | 88 (15) | 156 (13) | |
Comorbidities | ||||
Dyslipidemia, n (%) | 549 (30) | 254 (42) | 295 (24) | < 0.0001 |
Obesity, n (%) | 588 (33) | 265 (44) | 323 (27) | < 0.0001 |
CCI (SD) | 3.1 (2.6) | 3.8 (2.5) | 2.8 (2.5) | < 0.0001 |
Immunoglobulin Concentrations | ||||
IgA, mg/dL(SD) | 260 (239) | 267 (171) | 256 (268) | 0.3875 |
IgG, mg/dL(SD) | 1099 (629) | 1093 (572) | 1102 (655) | 0.7577 |
IgM, mg/dL(SD) | 112 (256) | 97 (134) | 120 (301) | 0.0736 |